Search Medical Condition
Please enter condition
Please choose location from dropdown

Dothan, Alabama Clinical Trials

A listing of Dothan, Alabama clinical trials actively recruiting patient volunteers.

RESULTS

Found (47) clinical trials

A Study to Evaluate the Safety and Tolerability of Long-term Therapy With TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

This is an open-label Phase 3 study with a 2-week, double-blind, placebo-controlled, randomized drug withdrawal period to evaluate the safety and efficacy of TEV-50717 tablets in patients who have previously completed participation in Study SD-809-C-17, Study TV50717-CNS-30046, or Study TV50717-CNS-30060.

Phase

8.34 miles

Learn More »

Evaluation of SPN-812 ER Low Dose in Children With ADHD

This is a multicenter, randomized, double-blind, placebo-controlled, 3-arm, parallel-group study, to assess the efficacy and safety of SPN-812 ER as monotherapy for the treatment of children 6-11 years old with ADHD.

Phase

8.34 miles

Learn More »

Evaluation of SPN-812 ER Low Dose in Adolescents With ADHD

This is a multicenter, randomized, double-blind, placebo-controlled, 3-arm, parallel-group study, to assess the efficacy and safety of SPN-812 ER as monotherapy for the treatment of adolescents 12-17 years old with ADHD.

Phase

8.34 miles

Learn More »

A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension

This study will evaluate the efficacy, safety, and pharmacokinetics of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults (18 years and older) with autism spectrum disorder (ASD).

Phase

8.34 miles

Learn More »

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

This is a multicenter, randomized, double-blind, placebo- and active-controlled trial to evaluate the safety and efficacy of brexpiprazole monotherapy compared to placebo in adolescent subjects (ages 13-17) with a DSM-5 diagnosis of schizophrenia.

Phase

8.34 miles

Learn More »

Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.

This is a study to evaluate the efficacy and safety of deutetrabenazine (TEV-50717) tablets for the reduction of motor and phonic tics associated with TS in children and adolescents 6 through 16 years of age.

Phase

8.34 miles

Learn More »

The Kites research study If your child is affected by depression and still experiencing its symptoms – you may be interested in the Kites study. Kites is an international clinical research study that is looking at the safety and effectiveness of an investigational medicinal product for major depression in children ...

Phase

8.34 miles

Learn More »